Loading…

FTY720 attenuates lesional interleukin-17+ cell accumulation in rat experimental autoimmune neuritis

Aims: Experimental autoimmune neuritis (EAN) is a well‐known animal model of human demyelinating polyneuropathies. Here we have studied the spatiotemporal accumulation of interleukin (IL)‐17+ cells in sciatic nerves of EAN rats and effects of FTY720, an agonist of sphingosine‐1‐phosphate (S1P) recep...

Full description

Saved in:
Bibliographic Details
Published in:Neuropathology and applied neurobiology 2009-10, Vol.35 (5), p.487-495
Main Authors: Zhang, Z-Y., Zhang, Z., Schluesener, H. J.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Aims: Experimental autoimmune neuritis (EAN) is a well‐known animal model of human demyelinating polyneuropathies. Here we have studied the spatiotemporal accumulation of interleukin (IL)‐17+ cells in sciatic nerves of EAN rats and effects of FTY720, an agonist of sphingosine‐1‐phosphate (S1P) receptors. Methods: In this study, we examined the spatiotemporal expression of IL‐17 using immunohistochemistry and RT‐PCR, and analysed the IL‐17+ cell proportion in blood and lymph nodes using flow cytometry. Results: In sciatic nerves of EAN rats, IL‐17+ cells were mainly found to concentrate around blood vessels and IL‐17+ cell accumulation was temporally correlated with severity of neurological signs. FTY720, which has been shown to reduce severity of EAN, attenuated accumulation of IL‐17+ cells in sciatic nerves, decreased IL‐17+ cell proportion in peripheral blood, but increased IL‐17+ cell proportion in lymph nodes, suggesting the involvement of S1P signal pathway in regulating IL‐17+ cell trafficking. Conclusions: our data are consistent with the possibility that IL‐17+ cells might contribute to the pathogenesis of EAN and the S1P signal pathway may be involved in the in vivo trafficking of IL‐17+ cells.
ISSN:0305-1846
1365-2990
DOI:10.1111/j.1365-2990.2009.01016.x